Hyperthermia European Adjuvant Trial

  • participants needed
  • sponsor
    Klinikum der Universitaet Muenchen, Grosshadern
Updated on 15 September 2023


Improvement of the clinical outcome in patients with resectable pancreatic carcinoma through an intensified adjuvant treatment with gemcitabine, cisplatin and regional deep hyperthermia as compared to standard chemotherapy.

Condition Resected Pancreatic Adenocarcinoma
Treatment Gemcitabine + Cisplatin + regional hyperthermia, Gemcitabine + Capecitabine
Clinical Study IdentifierNCT01077427
SponsorKlinikum der Universitaet Muenchen, Grosshadern
Last Modified on15 September 2023

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note